Product Information

BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB is a generic product labeled by Unichem Pharmaceuticals (USA) Inc., priced at $0.2146 per EA under NDC 29300018701. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on Jul 28, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB

bisoprolol fumarate and hydrochlorothiazide
$0.2146per EA

Strength

2.5; 6.25 mg/1; mg/1

NDC

29300018701

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA079106

FDA Approved

7/28/2010

TE Code

AB

On Market Since

10/12/2010

Pharmacological Classes

Adrenergic beta-Antagonists
Increased Diuresis
Thiazide Diuretic
Thiazides
beta-Adrenergic Blocker

Price Statistics

The NADAC for BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 141.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2146 per EA
All-time high$0.4799 (May 15, 2019)
All-time low$0.0618 (Apr 19, 2017)
52-week high$0.2146
52-week low$0.1855
Median price$0.2105
Average price$0.2324
Largest weekly change+316.7% (Aug 22, 2018)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

+4.3%

1M

+4.3%

3M

+14.0%

6M

+14.9%

1Y

+0.3%

3Y

-28.6%

5Y

-35.1%

All

+141.5%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB?

The current National Average Drug Acquisition Cost (NADAC) for BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB, manufactured by Unichem Pharmaceuticals (USA) Inc., is $0.2146 per EA (NDC 29300018701), effective Aug 19, 2026.

How has the price of BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB changed over time?

Over the history we have for it, the NADAC for BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB has risen 141.5%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB?

Since Nov 28, 2013, the NADAC for BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB has ranged from a low of $0.0618 (Apr 19, 2017) to a high of $0.4799 (May 15, 2019), with a median of $0.2105 per EA.

Are there cheaper alternatives to BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB?

4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB in a comparable dosage form, but none are currently priced below it.

Who manufactures BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB?

BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB (NDC 29300018701) is labeled by Unichem Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.